Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Not yet recruiting × Ototoxicity × Clear all

Phase

Status

Completed 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 184 Neoplasms 170 Colorectal Neoplasms 81 Lung Neoplasms 80 Prostatic Neoplasms 77 Carcinoma, Non-Small-Cell Lung 45 Motor Activity 42 Stomach Neoplasms 41 Carcinoma, Hepatocellular 40 Anxiety Disorders 40 Uterine Cervical Neoplasms 34 Rectal Neoplasms 31 Pancreatic Neoplasms 31 Depression 28 Colonic Neoplasms 28 Head and Neck Neoplasms 26 Multiple Myeloma 24 Pain 22 Brain Neoplasms 22 Esophageal Neoplasms 21 Polycystic Ovary Syndrome 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Endometrial Neoplasms 19 Disease 19 Ovarian Neoplasms 18 Hematologic Neoplasms 18 Pain, Postoperative 17 Liver Neoplasms 17 Glioblastoma 16 Urinary Bladder Neoplasms 15

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06957132 2025-05-04

RISP-OTOTOX

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Not yet recruiting

Ototoxicity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡